Fundz

Fundz Deep Dive

Everything you need to win Geoff Nilsen — in one platform.

Who to reach, what to say, and why now on Geoff Nilsen — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Geoff Nilsen — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Nashville Biosciences Appoints Dan Benetz As Chief Financial Officer and Geoff Nilsen As Vice President and Head of Omics

PRIVATEJul 23, 2024•almost 2 years ago

Position

Head of Omics

Company

NashBio

Geoff Nilsen
NashvilleBiotechnology

Description

Nashville Biosciences, LLC (NashBio) announces the appointment of Dan Benetz as its chief financial officer (CFO) and Geoff Nilsen as vice president and head of omics. The company has also made internal promotions for Curt Allen to vice president of sales and Wacey Richards to vice president of engineering.

Company Information

Company

NashBio

Location

Nashville, Tennessee, United States

About

NashBio, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, NashBio serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for NashBio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.